Literature DB >> 1622844

Lung protein leakage in respiratory failure induced by a hybridoma making monoclonal antibody to the hydrophobic surfactant-associated polypeptide SP-B.

Y Suzuki1, B Robertson, Y Fujita, G Grossmann, K Kogishi, T Curstedt.   

Abstract

Adult mice were inoculated intraperitoneally with a hybridoma (8B5E) making monoclonal antibody to the porcine surfactant-associated polypeptide SP-B; this antibody cross-reacts with the corresponding polypeptide in the mouse surfactant system. Respiratory failure, developing 7-9 days after inoculation, was associated with a decrease in lung-thorax compliance determined during artificial ventilation, and an increase in the amount of protein including the specific antibody in lung lavage fluid. There was a statistically significant negative correlation between the compliance and the amount of protein as well as antibody recovered by lung lavage: r (log scale) = -0.69 and -0.82, respectively (P less than 0.01, both), but no decrease in the amount of phospholipids in lung lavage from animals inoculated with the hybridoma. Treatment with a large dose of porcine surfactant (about 320 mg phospholipids/kg body weight) had no positive effect on lung-thorax compliance during artificial ventilation; on the contrary, surfactant-treated animals showed a decrease in compliance similar to that seen in control animals after instillation of a similar volume of saline into the airways. We conclude that respiratory failure developing after inoculation with this hybridoma is probably at least in part mediated by flooding of the airspaces with antibody interfering with surfactant function.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1622844      PMCID: PMC2002332     

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  23 in total

1.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

2.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

3.  Low-molecular-mass surfactant protein type 1. The primary structure of a hydrophobic 8-kDa polypeptide with eight half-cystine residues.

Authors:  T Curstedt; J Johansson; J Barros-Söderling; B Robertson; G Nilsson; M Westberg; H Jörnvall
Journal:  Eur J Biochem       Date:  1988-03-15

4.  Artificial pulmonary surfactant inhibited by proteins.

Authors:  T Fuchimukai; T Fujiwara; A Takahashi; G Enhorning
Journal:  J Appl Physiol (1985)       Date:  1987-02

5.  Two hydrophobic low-molecular-mass protein fractions of pulmonary surfactant. Characterization and biophysical activity.

Authors:  T Curstedt; H Jörnvall; B Robertson; T Bergman; P Berggren
Journal:  Eur J Biochem       Date:  1987-10-15

6.  Biophysical activity of synthetic phospholipids combined with purified lung surfactant 6000 dalton apoprotein.

Authors:  R H Notter; D L Shapiro; B Ohning; J A Whitsett
Journal:  Chem Phys Lipids       Date:  1987-06       Impact factor: 3.329

7.  Proteolipid in bovine lung surfactant: its role in surfactant function.

Authors:  A Takahashi; T Fujiwara
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

8.  Development of synthetic lung surfactants.

Authors:  Y Tanaka; T Takei; T Aiba; K Masuda; A Kiuchi; T Fujiwara
Journal:  J Lipid Res       Date:  1986-05       Impact factor: 5.922

9.  Hydrophobic surfactant-associated protein in whole lung surfactant and its importance for biophysical activity in lung surfactant extracts used for replacement therapy.

Authors:  J A Whitsett; B L Ohning; G Ross; J Meuth; T Weaver; B A Holm; D L Shapiro; R H Notter
Journal:  Pediatr Res       Date:  1986-05       Impact factor: 3.756

10.  Respiratory failure in mice caused by a hybridoma making antibodies to the 15 kDa surfactant apoprotein.

Authors:  Y Suzuki; B Robertson; Y Fujita; G Grossmann
Journal:  Acta Anaesthesiol Scand       Date:  1988-05       Impact factor: 2.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.